Kenneth Maynard, DO
Family Medicine · Lizton, INNPI 1730103730
Payments from drug & device makers
Across 520 payments — averaging $2197.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$407K
- Pfizer$368K
- Eli Lilly$137K
- AstraZeneca$102K
- Vivus LLC$74K
- Cipla USA Inc.$45K
- plus $9K from 29 others
Across 2 payments — averaging $764.54 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$2K
- Eli Lilly Export S.A. Puerto Rico Branch$27
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 156 | $406,724 |
| Pfizer | 69 | $368,117 |
| Eli Lilly | 7 | $137,066 |
| AstraZeneca | 56 | $101,966 |
| Vivus LLC | 8 | $74,457 |
| Cipla USA Inc. | 23 | $45,346 |
| Abbott | 3 | $5,526 |
| Novo Nordisk | 70 | $1,213 |
| Otsuka America Pharmaceutical, Inc. | 21 | $370 |
| Exact Sciences | 14 | $280 |
| Lilly USA, LLC | 20 | $238 |
| GSK | 11 | $223 |
| Ironshore Pharmaceuticals Inc. | 8 | $161 |
| Phathom Pharmaceuticals, Inc. | 5 | $150 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $107 |
| Eisai Inc. | 5 | $103 |
| Novartis | 6 | $84 |
| Biohaven Pharmaceuticals, Inc. | 3 | $63 |
| Bayer | 3 | $62 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $61 |
| Daiichi Sankyo Inc. | 3 | $53 |
| Amarin Pharma, Inc. | 2 | $39 |
| Ultragenyx Pharmaceutical Inc. | 2 | $37 |
| Amgen(2 entities) | 2 | $31 |
| Corium, LLC | 1 | $30 |
| Mylan Specialty L.p. | 2 | $30 |
| Kowa Pharmaceuticals America, Inc. | 2 | $27 |
| Paratek Pharmaceuticals, Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $21 |
| Astellas Pharma US Inc | 1 | $17 |
| Dynavax Technologies Corporation | 1 | $15 |
| Antares Pharma, Inc. | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
| Shire North American Group Inc | 1 | $11 |
How this compares
$1,142,688 in reported general payments places this provider in the 95th percentile of 2,709 family medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in Lizton
- Blair BrengleIndianapolis$10.6M
- Laura HelmanMishawaka$4M
- J Christopher SartoreEvansville$3.9M
- Hubert ReyesEvansville$3.2M
- David SchultzEvansville$3M
- Steven SmithIndianapolis$2.5M
- Renee Michelle GalenNewburgh$2.1M
- Eric HewittAvon$1.7M
- Alexander Dela LlanaEvansville$1.6M
- Jonathan ConditMuncie$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.